We are live on
!
Find out more
GA
Gagnon Advisors Portfolio holdings
AUM
$136M
1-Year Est. Return
21.55%
This Fund
S&P 500
This Quarter
Est. Return
+3.45%
1 Year Est. Return
+21.55%
3 Year Est. Return
+78.18%
5 Year Est. Return
+93.01%
10 Year Est. Return
+1,298.31%
AUM
$158M
AUM Growth
-$4.44M
(-2.7%)
Cap. Flow
-$2.88M
Cap. Flow
% of AUM
-1.83%
Top 10 Holdings %
Top 10 Hldgs %
65.25%
Holding
24
New
–
Increased
7
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIVE9
FIVN
|
+$3.58M |
| 2 |
Treace Medical Concepts
TMCI
|
+$2.46M |
| 3 |
Pacira BioSciences
PCRX
|
+$1.13M |
| 4 |
Amplitude
AMPL
|
+$1.1M |
| 5 |
MarineMax
HZO
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freshworks
FRSH
|
+$6.67M |
| 2 |
Aspen Aerogels
ASPN
|
+$3.94M |
| 3 |
DoubleVerify
DV
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.41% |
| 2 | Technology | 24.49% |
| 3 | Industrials | 16.8% |
| 4 | Energy | 12.6% |
| 5 | Real Estate | 5.21% |
Similar funds
WF
MWA
SSCM
BDCMI
RC
LWM
WA
LCM
Gagnon Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Gagnon Advisors held 24 positions worth $158M, down 2.7% from $162M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.2%. Gagnon Advisors opened no new positions and exited 1, leaving the 24-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.
- Gagnon Advisors added most to FIVE9 in Q4 2025, an estimated $3.58M increase.
- Gagnon Advisors's biggest Q4 2025 reduction was Freshworks, cutting an estimated $6.67M.
- Gagnon Advisors fully exited Aspen Aerogels in Q4 2025, selling an estimated $3.94M.
- Gagnon Advisors's ten largest holdings make up 65% of its $158M portfolio in Q4 2025.
- Gagnon Advisors opened 0 new positions and closed 1 in Q4 2025.
- Gagnon Advisors's portfolio value fell 2.7% quarter-over-quarter to $158M.
Based on Gagnon Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.